Verastem, Inc. Long-term Debt, Gross
Verastem, Inc. (VSTM) had Long-term Debt, Gross of $40.00 million as of 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-03-04
- 2024-12-31: Long-term Debt, Gross $40.00M.
- 2024-09-30: Long-term Debt, Gross $40.00M.
- 2024-06-30: Long-term Debt, Gross $40.00M.
- 2024-03-31: Long-term Debt, Gross $40.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-12-31 | $40.00M 10-K · filed 2026-03-04 |
| 2024-09-30 | $40.00M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $40.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $40.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $40.00M 10-K · filed 2025-03-20 |
| 2023-09-30 | $40.00M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $40.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $40.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $25.00M 10-K · filed 2024-03-14 |
| 2022-09-30 | $25.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $25.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $25.00M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2019-12-31 | $35.10M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |